SIEN.Q Stock Overview
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Sientra, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.066 |
| 52 Week High | US$4.94 |
| 52 Week Low | US$0.05 |
| Beta | 2.02 |
| 1 Month Change | -28.40% |
| 3 Month Change | -88.38% |
| 1 Year Change | -95.57% |
| 3 Year Change | -99.90% |
| 5 Year Change | -99.92% |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Fewer Investors Than Expected Jumping On Sientra, Inc. (NASDAQ:SIEN)
Apr 17
Sientra slides 18% on proposes stock offering
Oct 19Sientra refinances convertible debt at heavy premiums, sees Q3 revenue in-line
Oct 12Sientra gets regulatory nod to market breast implants in Saudi Arabia
Sep 20Sientra GAAP EPS of -$0.29 misses by $0.06, revenue of $21.5M misses by $2.26M
Aug 11FDA approves Sientra’s breast implant product for breast augmentation, reconstruction
Jul 06Sientra (NASDAQ:SIEN) Is Carrying A Fair Bit Of Debt
Apr 16Is Sientra (NASDAQ:SIEN) Using Too Much Debt?
Jan 06Shareholder Returns
| SIEN.Q | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -5.7% | -4.4% | -3.7% |
| 1Y | -95.6% | -2.8% | 20.2% |
Return vs Industry: SIEN.Q underperformed the US Medical Equipment industry which returned -2.2% over the past year.
Return vs Market: SIEN.Q underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| SIEN.Q volatility | |
|---|---|
| SIEN.Q Average Weekly Movement | 51.9% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SIEN.Q's share price has been volatile over the past 3 months.
Volatility Over Time: SIEN.Q's weekly volatility has increased from 32% to 52% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 304 | Ron Menezes | sientra.com |
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers.
Sientra, Inc. Fundamentals Summary
| SIEN.Q fundamental statistics | |
|---|---|
| Market cap | US$789.21k |
| Earnings (TTM) | -US$59.33m |
| Revenue (TTM) | US$90.30m |
0.0x
P/S Ratio0.0x
P/E RatioIs SIEN.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIEN.Q income statement (TTM) | |
|---|---|
| Revenue | US$90.30m |
| Cost of Revenue | US$52.28m |
| Gross Profit | US$38.02m |
| Other Expenses | US$97.35m |
| Earnings | -US$59.33m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.96 |
| Gross Margin | 42.11% |
| Net Profit Margin | -65.71% |
| Debt/Equity Ratio | -183.5% |
How did SIEN.Q perform over the long term?
See historical performance and comparison